SIRT1 is increased in affected brain regions and hypothalamic metabolic pathways are altered in Huntington disease von Baldo, B., Gabery, S., Soylu‐Kucharz, R., Cheong, R. Y., Henningsen, J. B., Englund, E., McLean, C., Kirik, D., Halliday, G., Petersén, Å.

Volltext

Detailed assessment of hypothalamic damage in craniopharyngioma patients with obesity von Fjalldal, S., Follin, C., Gabery, S., Sundgren, P. C., Björkman-Burtscher, I. M., Lätt, J., Mannfolk, P., Nordström, C. H., Rylander, L., Ekman, B., Cheong, R., Pålsson, A., Petersén, Å., Erfurth, E. M.

Volltext

Microstructural white matter alterations and hippocampal volumes are associated with cognitive deficits in craniopharyngioma von Fjalldal, S., Follin, C., Svärd, Daniel, Rylander, L., Gabery, S., Petersen, A., van Westen, D., Sundgren, P. C., Bjorkman-Burtscher, I. M., Latt, J., Ekman, Bertil, Johanson, A., Erfurth, E. M.

Volltext

HTA57 Quantifying Heterogeneity within and between Treatment Guidelines for Type 2 Diabetes: Potential Implications for EU-Wide Health Technology Assessment von Nielsen, N., Hunt, B., Malkin, SJP, Gabery, S., Acs, A.

Volltext

Selective loss of oxytocin and vasopressin in the hypothalamus in early Huntington disease: a case study von Gabery, Sanaz, Halliday, Glenda, Kirik, Deniz, Englund, Elisabet, Petersén, Åsa

Volltext

H04Gene Expression Changes In Emotion And Metabolism Regulating Neuropeptide Systems In The Hypothalamus In Clinical Huntington Disease von Gabery, S, Soylu-Kucharz, R, McLean, C, Kirik, D, Halliday, G, Petersen, Aa

Volltext

H04 Gene Expression Changes In Emotion And Metabolism Regulating Neuropeptide Systems In The Hypothalamus In Clinical Huntington Disease von Gabery, S., Soylu-Kucharz, R., McLean, C., Kirik, D., Halliday, G., Petersen, A.

Volltext

C09Characterisation of a rat model of Huntington's disease based on targeted expression of a mutant huntingtin fragment in the forebrain using an adeno-associated viral vector von Gabery, S, Sajjad, MU, Hult, S, Soylu, R, Kirik, D, Petersen, Aa

Volltext

C09 Characterisation of a rat model of Huntington's disease based on targeted expression of a mutant huntingtin fragment in the forebrain using an adeno-associated viral vector von Gabery, S, Sajjad, MU, Hult, S, Soylu, R, Kirik, D, Petersén, Å

Volltext

A23 Changes in key hypothalamic neuropeptide populations in Huntington's Disease revealed by neuropathological analyses von Gabery, S, Murphy, K, Schultz, K, Loy, C, McCusker, E, Kirik, D, Halliday, G, Petersén, Å

Volltext

Loss of the metabolism and sleep regulating neuronal populations expressing orexin and oxytocin in the hypothalamus in amyotrophic lateral sclerosis von Gabery, Sanaz, Ahmed, Rebekah M, Caga, Jashelle, Kiernan, Matthew C, Halliday, Glenda M, Petersén, Åsa

Volltext

Semaglutide lowers body weight in rodents via distributed neural pathways von Gabery, Sanaz, Salinas, Casper G., Paulsen, Sarah J., Ahnfelt-Ronne, Jonas, Alanentalo, Tomas, Baquero, Arian F., Buckley, Stephen T., Farkas, Erzsebet, Fekete, Csaba, Frederiksen, Klaus S., Helms, Hans Christian C., Jeppesen, Jacob F., John, Linu M., Pyke, Charles, Nohr, Jane, Lu, Tess T., Polex-Wolf, Joseph, Prevot, Vincent, Raun, Kirsten, Simonsen, Lotte, Sun, Gao, Szilvasy-Szabo, Anett, Willenbrock, Hanni, Secher, Anna, Knudsen, Lotte Bjerre

Volltext

Integrated Brain Atlas for Unbiased Mapping of Nervous System Effects Following Liraglutide Treatment von Salinas, Casper Bo Gravesen, Lu, Tess Tsai-Hsiu, Gabery, Sanaz, Marstal, Kasper, Alanentalo, Tomas, Mercer, Aaron Jeffrey, Cornea, Anda, Conradsen, Knut, Hecksher-Sørensen, Jacob, Dahl, Anders Bjorholm, Knudsen, Lotte Bjerre, Secher, Anna

Volltext

Efficacy and safety of once-daily oral semaglutide 25 mg and 50 mg compared with 14 mg in adults with type 2 diabetes (PIONEER PLUS): a multicentre, randomised, phase 3b trial von Aroda, Vanita R, Aberle, Jens, Bardtrum, Lars, Christiansen, Erik, Knop, Filip K, Gabery, Sanaz, Pedersen, Sue D, Buse, John B

Volltext

Early white matter pathology in the fornix of the limbic system in Huntington disease von Gabery, Sanaz, Kwa, Jing Eugene, Cheong, Rachel Y., Baldo, Barbara, Ferrari Bardile, Costanza, Tan, Brendan, McLean, Catriona, Georgiou-Karistianis, Nellie, Poudel, Govinda R., Halliday, Glenda, Pouladi, Mahmoud A., Petersén, Åsa

Volltext

Eating and hypothalamus changes in behavioral-variant frontotemporal dementia von Piguet, Olivier, Petersén, Åsa, Yin Ka Lam, Bonnie, Gabery, Sanaz, Murphy, Karen, Hodges, John R., Halliday, Glenda M.

Volltext

Oxytocin in Huntington’s disease and the spectrum of amyotrophic lateral sclerosis-frontotemporal dementia von Bergh, Sofia, Cheong, Rachel Y., Petersén, Åsa, Gabery, Sanaz

Volltext

Efficacy and safety of oral semaglutide monotherapy vs placebo in a predominantly Chinese population with type 2 diabetes (PIONEER 11): a double-blind, Phase IIIa, randomised trial von Wang, Weiqing, Bain, Stephen C., Bian, Fang, Chen, Rui, Gabery, Sanaz, Huang, Shan, Jensen, Thomas B., Luo, Bifen, Yuan, Guoyue, Ning, Guang

Volltext

Effects of mutant huntingtin in oxytocin neurons on non‐motor features of Huntington's disease von Bergh, Sofia, Gabery, Sanaz, Tonetto, Simone, Kirik, Deniz, Petersén, Åsa, Cheong, Rachel Y.

Volltext

Efficacy and safety of oral semaglutide vs sitagliptin in a predominantly Chinese population with type 2 diabetes uncontrolled with metformin: PIONEER 12, a double-blind, Phase III... von Ji, Linong, Agesen, Rikke M., Bain, Stephen C., Fu, Fangming, Gabery, Sanaz, Geng, Jianlin, Li, Yiming, Lu, Yibing, Luo, Bifen, Pang, Wuyan, Tao, Yi

Volltext